COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023
With the availability of authorized COVID-19 vaccines in early 2021, vaccination became an effective tool to reduce COVID-19-associated morbidity and mortality. Initially, the World Health Organization (WHO) set an ambitious target to vaccinate 70% of the global population by mid-2022. However, in July 2022, WHO recommended that all countries, including those in the African Region, prioritize COVID-19 vaccination of high-risk groups, including older adults and health care workers, to have the greatest impact on morbidity and mortality. As of December 31, 2023, approximately 860 million doses of COVID-19 vaccine had been delivered to countries in the African Region, and 646 million doses had been administered. Cumulatively, 38% of the African Region's population had received ≥1 dose, 32% had completed a primary series, and 21% had received ≥1 booster dose. Cumulative total population coverage with ≥1 dose ranged by country from 0.3% to 89%. Coverage with the primary series among older age groups was 52% (range among countries = 15%-96%); primary series coverage among health care workers was 48% (range = 13%-99%). Although the COVID-19 public health emergency of international concern was declared over in May 2023, current WHO recommendations reinforce the need to vaccinate priority populations at highest risk for severe COVID-19 disease and death and build more sustainable programs by integrating COVID-19 vaccination into primary health care, strengthening immunization across the life course, and improving pandemic preparedness.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
MMWR. Morbidity and mortality weekly report - 73(2024), 14 vom: 11. Apr., Seite 307-311 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Doshi, Reena H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.15585/mmwr.mm7314a3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM37092200X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM37092200X | ||
| 003 | DE-627 | ||
| 005 | 20240415233741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15585/mmwr.mm7314a3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM37092200X | ||
| 035 | |a (NLM)38602879 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Doshi, Reena H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a With the availability of authorized COVID-19 vaccines in early 2021, vaccination became an effective tool to reduce COVID-19-associated morbidity and mortality. Initially, the World Health Organization (WHO) set an ambitious target to vaccinate 70% of the global population by mid-2022. However, in July 2022, WHO recommended that all countries, including those in the African Region, prioritize COVID-19 vaccination of high-risk groups, including older adults and health care workers, to have the greatest impact on morbidity and mortality. As of December 31, 2023, approximately 860 million doses of COVID-19 vaccine had been delivered to countries in the African Region, and 646 million doses had been administered. Cumulatively, 38% of the African Region's population had received ≥1 dose, 32% had completed a primary series, and 21% had received ≥1 booster dose. Cumulative total population coverage with ≥1 dose ranged by country from 0.3% to 89%. Coverage with the primary series among older age groups was 52% (range among countries = 15%-96%); primary series coverage among health care workers was 48% (range = 13%-99%). Although the COVID-19 public health emergency of international concern was declared over in May 2023, current WHO recommendations reinforce the need to vaccinate priority populations at highest risk for severe COVID-19 disease and death and build more sustainable programs by integrating COVID-19 vaccination into primary health care, strengthening immunization across the life course, and improving pandemic preparedness | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Nsasiirwe, Sheillah |e verfasserin |4 aut | |
| 700 | 1 | |a Dahlke, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Atagbaza, Ajiri |e verfasserin |4 aut | |
| 700 | 1 | |a Aluta, Oniovo Efe |e verfasserin |4 aut | |
| 700 | 1 | |a Tatsinkou, Alain Blaise |e verfasserin |4 aut | |
| 700 | 1 | |a Dauda, Ezekiel |e verfasserin |4 aut | |
| 700 | 1 | |a Vilajeliu, Alba |e verfasserin |4 aut | |
| 700 | 1 | |a Gurung, Santosh |e verfasserin |4 aut | |
| 700 | 1 | |a Tusiime, Jayne |e verfasserin |4 aut | |
| 700 | 1 | |a Braka, Fiona |e verfasserin |4 aut | |
| 700 | 1 | |a Bwaka, Ado |e verfasserin |4 aut | |
| 700 | 1 | |a Wanyoike, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Brooks, Donald J |e verfasserin |4 aut | |
| 700 | 1 | |a Blanc, Diana Chang |e verfasserin |4 aut | |
| 700 | 1 | |a Alexander, James P |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Dahl, Benjamin A |e verfasserin |4 aut | |
| 700 | 1 | |a Lindstrand, Ann |e verfasserin |4 aut | |
| 700 | 1 | |a Wiysonge, Charles S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t MMWR. Morbidity and mortality weekly report |d 1984 |g 73(2024), 14 vom: 11. Apr., Seite 307-311 |w (DE-627)NLM012594334 |x 1545-861X |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2024 |g number:14 |g day:11 |g month:04 |g pages:307-311 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.15585/mmwr.mm7314a3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2024 |e 14 |b 11 |c 04 |h 307-311 | ||